Susquehanna Fundamental Investments LLC Has $11.26 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

Susquehanna Fundamental Investments LLC lowered its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 31.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 128,958 shares of the medical device company’s stock after selling 58,370 shares during the period. Susquehanna Fundamental Investments LLC owned about 0.06% of Cooper Companies worth $11,258,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in shares of Cooper Companies by 303.0% in the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after purchasing an additional 17,367,502 shares during the last quarter. Capital World Investors grew its holdings in shares of Cooper Companies by 301.7% in the 1st quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after purchasing an additional 4,246,519 shares during the last quarter. Janus Henderson Group PLC grew its holdings in shares of Cooper Companies by 279.8% in the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after purchasing an additional 2,532,186 shares during the last quarter. Bessemer Group Inc. grew its holdings in shares of Cooper Companies by 305.2% in the 1st quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock worth $203,013,000 after purchasing an additional 1,507,049 shares during the last quarter. Finally, Swedbank AB bought a new stake in shares of Cooper Companies in the 1st quarter worth about $139,246,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and upped their price target for the stock from $107.00 to $115.00 in a research report on Tuesday, July 16th. Stifel Nicolaus restated a “buy” rating and set a $115.00 target price (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Wells Fargo & Company upped their target price on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Morgan Stanley upped their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. Finally, Piper Sandler upped their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Four investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average price target of $115.00.

Insider Buying and Selling

In related news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the sale, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CEO Albert G. White III sold 114,992 shares of the firm’s stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the transaction, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the transaction, the chief accounting officer now directly owns 4,818 shares of the company’s stock, valued at $520,488.54. The disclosure for this sale can be found here. In the last three months, insiders sold 256,373 shares of company stock valued at $27,637,427. 2.00% of the stock is owned by corporate insiders.

Cooper Companies Stock Performance

Shares of NASDAQ:COO opened at $109.78 on Friday. The company has a market capitalization of $21.86 billion, a price-to-earnings ratio of 64.58, a P/E/G ratio of 2.63 and a beta of 0.98. The firm’s 50 day simple moving average is $99.84 and its 200 day simple moving average is $95.77. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The Cooper Companies, Inc. has a fifty-two week low of $75.93 and a fifty-two week high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The business had revenue of $1 billion during the quarter, compared to analysts’ expectations of $997.30 million. During the same period in the prior year, the business earned $0.84 EPS. Cooper Companies’s revenue for the quarter was up 7.8% compared to the same quarter last year. As a group, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.